During the past decade, Latin Clinical Trial Center conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 5 clinical trials were completed, i.e. on average, 125% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 2 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Latin Clinical Trial Center" are "Rheumatoid Arthritis" (2 trials), "Axial Spondyloarthritis" (1 trials), "Lupus Erythematosus, Systemic" (1 trials) and "Systemic Lupus Erythematosus" (1 trials). Many other conditions were trialed in "Latin Clinical Trial Center" in a lesser frequency.

Most popular intervention types in "Latin Clinical Trial Center" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (3 trials), "Baricitinib" (2 trials), "Adalimumab" (1 trials), "Adalimumab Placebo" (1 trials) and "Baricitinib Placebo" (1 trials). Other intervention names were less common.

The vast majority of trials in "Latin Clinical Trial Center" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Latin Clinical Trial Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Latin Clinical Trial Center, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Latin Clinical Trial Center, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".